Stress Hyperglycemia Ratio as a Prognostic Marker in Diabetic Patients Hospitalized with COVID-19

Evidence is conflicting about the diabetes characteristics associated with worse outcome among hospitalized COVID-19 patients. We aimed to assess the role of stress hyperglycemia ratio (SHR) as a prognostic marker among them. In our retrospective cohort study, patients were stratified according to S...

Full description

Saved in:
Bibliographic Details
Published in:Infectious disease reports 2022-09, Vol.14 (5), p.675-685
Main Authors: Aon, Mohamed, Alsaeedi, Abdullah, Alzafiri, Azeez, Al-Shammari, Abdelrahman, Taha, Sherif, Al-Shammari, Omar, Tawakul, Mahmoud, Alshammari, Jarrah, Alherz, Naser, Alenezi, Monerah, Eyadah, Meshari, Aldhafeeri, Mariam, Alharbi, Teflah, Alshammari, Duaa, Alenezi, Zaid, Aldouseri, Salem, Albazee, Ebraheem, Ibrahim, Mohamed M., Aoun, Ahmed H.
Format: Article
Language:English
Subjects:
Comorbidity
Coronaviruses
COVID-19
Diabetes
Diabetes mellitus
Glucose
Hemoglobin
Hospitalization
Hyperglycemia
Laboratories
Markers
Mechanical ventilation
Mortality
Oxygen therapy
Patients
Pneumonia
Respiratory diseases
Risk analysis
Risk factors
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Steroids
stress hyperglycemia ratio
Ventilators
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Evidence is conflicting about the diabetes characteristics associated with worse outcome among hospitalized COVID-19 patients. We aimed to assess the role of stress hyperglycemia ratio (SHR) as a prognostic marker among them. In our retrospective cohort study, patients were stratified according to SHR, admission glucose, and glycated hemoglobin tertiles. The primary outcome was a composite endpoint of invasive mechanical ventilation, intensive care unit admission, and in-hospital mortality. The study included 395 patients with a mean age of 59 years, and 50.1% were males. Patients in the third tertile of SHR developed more primary events, and the difference was significant compared to the first tertile (p = 0.038) and close to significance compared to the second tertile (p = 0.054). There was no significant difference in the outcomes across admission glucose and glycated hemoglobin tertiles. A higher SHR tertile was an independent risk factor for the primary outcome (OR, 1.364; 95% CI: 1.014–1.836; p = 0.040) after adjustment for other covariables. In hospitalized COVID-19 diabetic patients, SHR third tertile was significantly associated with worse outcome and death. SHR can be a better prognostic marker compared to admission glucose and glycated hemoglobin. A higher SHR was an independent risk factor for worse outcome and in-hospital mortality.
ISSN:2036-7449
2036-7430
2036-7449
DOI:10.3390/idr14050073